HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 179 filers reported holding HERON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $118,000 | -63.7% | 20,600 | -7.0% | 0.00% | -83.3% |
Q2 2020 | $325,000 | +8025.0% | 22,146 | +7282.0% | 0.02% | – |
Q1 2020 | $4,000 | -42.9% | 300 | +2.0% | 0.00% | – |
Q4 2019 | $7,000 | +250.0% | 294 | +143.0% | 0.00% | – |
Q2 2019 | $2,000 | -99.1% | 121 | -98.7% | 0.00% | -100.0% |
Q1 2019 | $221,000 | -72.1% | 9,051 | -63.8% | 0.01% | -73.9% |
Q3 2018 | $791,000 | -39.7% | 24,986 | -26.0% | 0.05% | -44.6% |
Q2 2018 | $1,311,000 | +16.1% | 33,748 | -17.5% | 0.08% | +1.2% |
Q1 2018 | $1,129,000 | +19.6% | 40,910 | -21.6% | 0.08% | +7.9% |
Q4 2017 | $944,000 | +53.7% | 52,163 | +37.1% | 0.08% | +38.2% |
Q3 2017 | $614,000 | +1705.9% | 38,043 | +1802.2% | 0.06% | +1275.0% |
Q3 2016 | $34,000 | -62.2% | 2,000 | -57.9% | 0.00% | -69.2% |
Q1 2016 | $90,000 | +4400.0% | 4,747 | +4647.0% | 0.01% | – |
Q3 2015 | $2,000 | -60.0% | 100 | -75.0% | 0.00% | -100.0% |
Q2 2014 | $5,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |